Lecture 3: G-Protein Coupled Receptors (GPCRs)
Introduction to G-Protein Coupled Receptors (GPCRs)
Clinical Significance:
GPCRs are the largest class of drug targets, accounting for roughly 30% of all drugs currently on the market. Drugs act as either agonists (activating) or antagonists (inhibiting).
GPCR Structure and Signal Initiation
Structural Composition:
Transmembrane Domains: 7 trans-membrane alpha helical domains (multi-pass proteins).
Cytosolic and Extracellular Domains: 4 domains located on each side of the cell
Ligand Binding and Activation:
GPCRs interact with a wide range of ligands including hormones (Glucagon, Epinephrine, Vasopressin, Serotonin, TSH), metabolites, and light.
Specific residues on the internal (hydrophobic) surface of the transmembrane alpha helices form a highly specific interaction surface for ligands.
The GEF Role: Upon ligation, the receptor undergoes structural changes that convert the inactive receptor into a Guanine-nucleotide Exchange Factor (GEF). This allows the receptor to interact with the trimeric G-protein complex.
Signal Relay by Trimeric G-Proteins
Mechanism of the Molecular Switch:
G-proteins exist in an "off" state when bound to Guanosine diphosphate (GDP).
They switch to an "on" state by exchanging GDP for Guanosine triphosphate (GTP).
The signal is turned off when the G-protein hydrolyses GTP back into GDP and inorganic phosphate.
The Trimeric Complex Components:
The complex consists of three subunits: , , and .
The subunit is the primary component that binds GTP or GDP.
At the "Resting State," the trimeric complex is bound together with GDP in the subunit.
Step-by-Step Activation:
Ligand Binding: Hormone binds to the GPCR, inducing a conformational change in C3 and C4 that forms docking site for G protein.
Receptor-G Protein Interaction: The active receptor docks with the G-trimer.
Nucleotide Exchange: The receptor acts as a GEF, changing the shape of , which decreases its affinity for GDP and increases its affinity for GTP.
Dissociation: The binding of GTP triggers the dissociation of from both the receptor and the complex.
Effector Activation: The dissociated (and sometimes the complex) binds to and activates an effector protein.
Deactivation: The hormone dissociates from the receptor. The signalling concludes when hydrolyses GTP to GDP, causing it to dissociate from the effector and re-associate with .
G-Protein Diversity and Effector Pathways
The specific type of subunit dictates which effector pathway is activated.
Humans possess 21 different subunits, 6 different subunits, and 12 different subunits.
Effectros usually activated by protein
The Adenylate Cyclase and PKA Pathway
Adenylate (Adenylyl) Cyclase (AC):
GCPR use AC as effector, cAMP as second messenger.
Structure: A multi-pass transmembrane protein with two cytosolic catalytic domains.
Activation (): Induces a conformational change that brings the two catalytic domains together to form an active site.
Inhibition (): Induces a conformational change that forces catalytic domains apart.
Reaction: AC catalyses the conversion of ATP to cyclic AMP (cAMP) by cleaving the and phosphates.
Protein Kinase A (PKA):
Inactive State: Consists of 4 subunits: 2 catalytic subunits inhibited by 2 regulatory subunits.
Activation: cAMP binds to the regulatory subunits, inducing a conformational change that releases the catalytic subunits.
Function: PKA is a Serine/Threonine kinase that phosphorylates various target proteins to trigger cellular responses.
PKA can trigger biological response by converting glycogen ←→ glucose via phosphorylation
The Phospholipase C (PLC) and Calcium Pathway
Mechanism:
GPCRs interacting with or activate Phospholipase C (lipid cutter), a plasma membrane-bound enzyme.
PLC hydrolyses the phosphoester bond in the phospholipid ().
Cleavage Products (Second Messengers):
Inositol-1,4,5-bis-phosphate (): It binds to and opens calcium channels, flooding the cytosol with .
Diacylglycerol (DAG): Remains anchored in the plasma membrane.
Protein Kinase C (PKC) Activation:
Inactive PKC binds to cytosolic , causing it to relocalise to the plasma membrane.
Once at the membrane, it binds to DAG, becoming fully active.
Active PKC phosphorylates target proteins like transcription factors and enzymes.
Calcium Signalling
Homeostasis: Cytosolic concentrations are maintained at very low levels in resting cells.
Ca2+ Sensing Proteins:
EF Hand Motifs: Found in proteins like Calmodulin.
C2 Domains: Found in Protein Kinase C.
Calmodulin Effects:
Calcium-bound calmodulin activates several enzymes, including:
kinase (CAM Kinase): General phosphorylation of multiple targets.
Myosin light chain kinase: Regulates smooth muscle contraction.
Glycogen Synthase Kinase: Inhibits glycogen synthesis.
Mechanisms for Turning Signaling Off
1. Turning off the GPCR:
Active GPCRs are phosphorylated on the 3rd intracellular loop and C-terminal tail by GPCR kinases (GRKs).
Phosphorylation prevents further G-protein recruitment and allows Arrestin proteins to bind.
Arrestins direct the receptor for internalisation (endocytosis). The receptor is then either dephosphorylated and recycled to the membrane or sent for degradation.
2. Turning off G-proteins:
The interaction between an active and its effector protein increases the intrinsic GTPase activity of the subunit.
GTP is hydrolysed to GDP, returning the trimeric G-protein to its inactive "off" state.
3. Turning off Second Messengers:
cAMP: Cleaved by cAMP Phosphodiesterase, which breaks the cyclic ring to produce 5'-AMP (which cannot signal).
: Dephosphorylated by phosphatases to become inert.
Revision Tips: The A's and C's
Adenylate Cyclase pathway (Follow the A's): Adenylate cyclase cAMP Protein Kinase A (PKA).
Phospholipase C pathway (Follow the C's): Phospholipase C Protein Kinase C (PKC) Calcium Calmodulin.